DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
April Armstrong, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of: Consultant: AbbVie, BI, Bristol-Myers Squibb, Dermira, Dermavant, Eli Lilly, EPI Health, Incyte, Janssen, LEO Pharma, Modernizing Medicine, Novartis AG, Ortho Dermatologics, Pfizer, Regeneron Pharmaceuticals, Sun Pharma, and UCB. Non-Promotional Speaker: AbbVie, Janssen. Grant/Research Support: Bristol-Myers Squibb, Dermavant, Dermira, Eli Lilly, and UCB.
David Cohen, MD, MPH, FAADhas had a financial agreement or affiliation during the past year with the following commercial interests in the form of: Consultant: Asana, Cosmetic Ingredient Review, Dermavant, Ferndale Laboratories, FIDE, FSJ, LEO, Medimetriks, Novartis, and UCB. Stock Shareholder: Brickell Biotech (past), Dermira (past), Kadmon, Medimetriks (past) and Timber Pharmaceuticals. Board of Directors: Dermira (past), Evommune, Kadmon, and Timber.
Kara Gooding, MMS, PA-C has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Incyte, Novartis Pharmaceuticals, Pfizer, and UCB. Speaker’s Bureau: Amgen, Almirall, LEO Pharma, and Pfizer.
Joseph Gorelick, MSN, FNP-Chas had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bristol Myers Squibb, Beiersdorf, Brickell, Incyte, Journey, and Novartis. Speaker’s Bureau: AbbVie, Beiersdorf, Janssen, Lilly, LEO, Novartis, Pfizer, Prugen, Regeneron Pharmaceuticals, Sanofi Genzyme, Sun Pharma, and Vyne. Stock Shareholder: 10X Genomics, AbbVie (past), Alnilam Pharmaceuticals, Bioline Rx, Fortress Biotech, G1 Therapeutics, Guardiant Health, Intuitive Surgical, LTD, Moderna, and Royalty Pharma.
Accreditation and Medical Education Support Disclosure:Erin Fletcher of Evolve Medical Education LLC have no real or apparent conflicts of interest to report. Stacey Moore of Physician Resources, LLC has no real or apparent conflicts of interest to report.
